ADVFN Logo ADVFN

We could not find any results for:
Make sure your spelling is correct or try broadening your search.

Trending Now

Toplists

It looks like you aren't logged in.
Click the button below to log in and view your recent history.

Sign Up

Already a member? Sign in

Top Brokers

More Brokers

Market Data
News
Trading Tools
Markets
Discover

Hot Features

Follow Feed

Connect with traders and investors in our Follow Feed community.

Options Flow

Explore comprehensive options data and use advanced filters with Options Flow.

Monitor

Organize and monitor your stock and asset watchlist with Monitor.
Sign In Premium IconPremium Help Menu
FTSE 100
8,179.68
0.00%
Dow Jones
39,164.06
0.09%
Gold vs US Dollar
2,325.815
-0.08%
Brent Oil
85.675
0.30%
Bitcoin
61,516.91
-0.15%
Pepperstone
Advertisement
Registration Strip Icon for charts Register for streaming realtime charts, analysis tools, and prices.
Get Started
  1. Home
  2. Investing
  3. Stocks
  4. USA
  5. NASDAQ

  6. Janux Therapeutics Inc (JANX) Share Price

JANX Janux Therapeutics Inc

40.34
0.54 (1.36%)
28 Jun 2024 - Closed
Delayed by 15 minutes
 Name  Symbol  Market  Type  ISIN  Description 
 Janux Therapeutics Inc NASDAQ:JANX NASDAQ Common Stock  
     Change  % Chg  Cur  Bid  Offer  High  Low  Open  Volume  Chg Time
Upgrade Icon
 		 RN  NRN 
   0.54 1.36 40.34 35.00 44.50 40.99 39.06 39.92 492,734 00:00:00   
 Sector  Turnover  Profit  EPS - Basic  PE ratio  Mkt Cap 
 Pharmaceutical Preparations 8.08M -58.29M -1.1242 -35.89 2.09B
 Type  Size  Price  Time  Units 
 23 49,900 40.34 21:26:04 USD
 
Pre-Market and After-Hours
Recent News
DateTimeSource
HeadlineMore JANX News
17/06/202422:02EDGAR2Form DEFA14A - Additional definitive proxy soliciting materials and Rule 14(a)(12) material
04/06/202400:02EDGAR2Form 144 - Report of proposed sale of securities
04/06/202400:02EDGAR2Form 144 - Report of proposed sale of securities
03/06/202423:48EDGAR2Form 144 - Report of proposed sale of securities
08/05/202414:13EDGAR2Form S-3ASR - Automatic shelf registration statement of securities of well-known seasoned issuers
07/05/202421:01BWJanux Therapeutics Reports First Quarter 2024 Financial Results and Business Highlights
08/03/202421:47EDGAR2Form S-8 - Securities to be offered to employees in employee benefit plans
Period
Draw mode
Data Downloads for JANX

Export historical price information open, high, low, close, volume (OHLCV) to Excel

Intraday price data (2 weeks, 1 minute bars)


Loading Follow Feed...

Latest Janux Therapeutics Inc Articles